Lee & Xiao’s Antitrust and Business Regulation practice focuses on complex and sometimes unfair issues encountered by our clients on U.S. antitrust and trade regulations relating to exclusive dealing arrangements, distribution and sales agency agreements, pricing, joint ventures, and strategic alliances. We also assist our clients take preventive measures and conduct executive briefing and on-site employee training seminars on key legal issues and internal company practice in order to minimize and ultimately avoid antitrust liability.
In addition, we also advise our clients on complex regulations imposed by U.S. administrative agencies such as the Food and Drug Administration (“FDA”) and the Federal Trade Commission (“FTC”), including FDA medical device registration and FTC product labeling issues.